SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
886 Gotta get back in the lab. This sitting around and waiting for others to do thscaram(o)uche-2/26/1999
885 GUFFAW (not a politically correct laugh, eom) scaram(o)uche-2/26/1999
884 *****OT***** <i>>Yeah, but, but, but..... what the hell happens on reBeltropolis Boy-2/26/1999
883 Great find, PB. Thanks. >> The repeat-dose regimen produced a longscaram(o)uche-2/26/1999
882 Not sure if this was posted before; more fuel to the fire: ncbi.nlm.nih.gov JPseudo Biologist-2/26/1999
881 Natural killer cells in relapsing-remitting MS: effect of treatment with interfHarold Engstrom-2/26/1999
880 We are seeing history made in this market according to veteran money manager JiJoe Dancy-2/25/1999
879 Our new partner: ontogeny.comJEB-2/23/1999
878 <i>>Yes, I agree but what about the upgrade. That's the confusing Beltropolis Boy-2/23/1999
877 JEB, I think few analysts are really capable of making upgrade or downgrade recHarold Engstrom-2/23/1999
876 Good morning Harold, Yes, I agree but what about the upgrade. That's the JEB-2/23/1999
875 JEB, I think Biogen just gave itself some flexibility. I wouldn't read verHarold Engstrom-2/23/1999
874 Chris, Biogen buys back 4MM shares. PJ puts out an upgrade with a target of 9JEB-2/22/1999
873 <b>Biogen OKs 5.3 pct stock buyback</b> February 22, 1999 04:20 PMBeltropolis Boy-2/22/1999
872 Harold, Here's a possible leading indicator as to what BGEN thinks of theiBiomaven-2/22/1999
871 ;-)...yuppo! What else could it be?JEB-2/19/1999
870 Abstract below shows INFb treatment for secondary progressive patients is imporHarold Engstrom-2/19/1999
869 <i>>Speaking of potential new upgrades, how about one from JPM ... NoBeltropolis Boy-2/19/1999
868 Speaking of potential new upgrades, how about one from JPM: go2net.newsalert.cJEB-2/18/1999
867 To all: More positive developments for Avonex: > > > Wednesday FebruSDR-SI-2/18/1999
866 Michael Murphy of the Cal Tech letter recently did an interview with SI's MJoe Dancy-2/16/1999
865 Abstract showing anti-CD40L (Biogen Phase II compound) as potential MS treatmenHarold Engstrom-2/8/1999
864 Yiiii Haaaaaaa, we broke 100 today!!!!!!! I dreamed of this back in 1988! NexJEB-2/3/1999
863 The FDA should fine the company (Serono) and it's CEO, separately.JEB-2/1/1999
862 harold. i don't have the skinny on the analyst meeting, but here's a bBeltropolis Boy-2/1/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News